Weill Cornell Researchers Develop Novel Anti-Body Vaccine that Blocks Addictive Nicotine Chemicals from Reaching the Brain
NEW YORK–(ENEWSPF)–June 28, 2012 — Researchers at Weill Cornell Medical College have developed and successfully tested in mice an innovative vaccine to treat nicotine addiction.
In the journal Science Translational Medicine, the scientists describe how a single dose of their novel vaccine protects mice, over their lifetime, against nicotine addiction. The vaccine is designed to use the animal’s liver…
